In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 2nd, 2008 | 22 | No |
(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.08 | 4.42 | -9.1 | 3 | 5 | 0 | 81 | 356.179 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 3.41e-02 g/l | DrugBank-experimental |
Target | GSK-3 | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNB-1-E | G2/mitotic-specific Cyclin B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 320 | 0.41 | Binding ≤ 10μM |
CCNB1-2-E | G2/mitotic-specific Cyclin B1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 320 | 0.41 | Binding ≤ 10μM |
CCNB2-2-E | G2/mitotic-specific Cyclin B2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 320 | 0.41 | Binding ≤ 10μM |
CCNB3-2-E | G2/mitotic-specific Cyclin B3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 320 | 0.41 | Binding ≤ 10μM |
CDK1-1-E | Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 320 | 0.41 | Binding ≤ 10μM |
CDK5-1-E | Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 83 | 0.45 | Binding ≤ 10μM |
E2AK2-1-E | Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 600 | 0.40 | Binding ≤ 10μM |
GSK3A-1-E | Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 5 | 0.53 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 5 | 0.53 | Binding ≤ 10μM |
Z104294-1-O | Cyclin-dependent Kinase 5/CDK5 Activator 1 (cluster #1 Of 2), Other | Other | 83 | 0.45 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 1995 | 0.36 | Functional ≤ 10μM |
Z80156-2-O | HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other | Other | 5400 | 0.34 | Functional ≤ 10μM |
Z80186-1-O | K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other | Other | 1300 | 0.37 | Functional ≤ 10μM |
Z80471-2-O | SH-SY5 (Bone Marrow Neuroblastoma Cells) (cluster #2 Of 3), Other | Other | 9500 | 0.32 | Functional ≤ 10μM |
Z80928-1-O | HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other | Other | 5200 | 0.34 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 320 | 0.41 | Binding ≤ 1μM |
CDK5_HUMAN | Q00535 | Cyclin-dependent Kinase 5, Human | 83 | 0.45 | Binding ≤ 1μM |
Z104294 | Z104294 | Cyclin-dependent Kinase 5/CDK5 Activator 1 | 83 | 0.45 | Binding ≤ 1μM |
CCNB_MARGL | P15206 | G2/mitotic-specific Cyclin B, Margl | 320 | 0.41 | Binding ≤ 1μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 320 | 0.41 | Binding ≤ 1μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 320 | 0.41 | Binding ≤ 1μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 320 | 0.41 | Binding ≤ 1μM |
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 5 | 0.53 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 5 | 0.53 | Binding ≤ 1μM |
E2AK2_HUMAN | P19525 | Interferon-induced, Double-stranded RNA-activated Protein Kinase, Human | 600 | 0.40 | Binding ≤ 1μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 320 | 0.41 | Binding ≤ 10μM |
CDK5_HUMAN | Q00535 | Cyclin-dependent Kinase 5, Human | 83 | 0.45 | Binding ≤ 10μM |
Z104294 | Z104294 | Cyclin-dependent Kinase 5/CDK5 Activator 1 | 83 | 0.45 | Binding ≤ 10μM |
CCNB_MARGL | P15206 | G2/mitotic-specific Cyclin B, Margl | 320 | 0.41 | Binding ≤ 10μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 320 | 0.41 | Binding ≤ 10μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 320 | 0.41 | Binding ≤ 10μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 320 | 0.41 | Binding ≤ 10μM |
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 5 | 0.53 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 5 | 0.53 | Binding ≤ 10μM |
E2AK2_HUMAN | P19525 | Interferon-induced, Double-stranded RNA-activated Protein Kinase, Human | 600 | 0.40 | Binding ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 5200 | 0.34 | Functional ≤ 10μM |
Z80156 | Z80156 | HL-60 (Promyeloblast Leukemia Cells) | 5400 | 0.34 | Functional ≤ 10μM |
Z80186 | Z80186 | K562 (Erythroleukemia Cells) | 1300 | 0.37 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 1584.89319 | 0.37 | Functional ≤ 10μM |
Z80471 | Z80471 | SH-SY5 (Bone Marrow Neuroblastoma Cells) | 10000 | 0.32 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
AKT phosphorylates targets in the cytosol | |
APC truncation mutants have impaired AXIN binding | |
APC/C:Cdc20 mediated degradation of Cyclin B | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
Condensation of Prometaphase Chromosomes | |
Condensation of Prophase Chromosomes | |
Constitutive PI3K/AKT Signaling in Cancer | |
CRMPs in Sema3A signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin B2 mediated events | |
DARPP-32 events | |
Degradation of beta-catenin by the destruction complex | |
Depolymerisation of the Nuclear Lamina | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
E2F mediated regulation of DNA replication | |
E2F-enabled inhibition of pre-replication complex formation | |
ERK1 activation | |
Factors involved in megakaryocyte development and platelet production | |
G0 and Early G1 | |
G1/S-Specific Transcription | |
G2/M DNA replication checkpoint | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
Inhibition of PKR | |
ISG15 antiviral mechanism | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MASTL Facilitates Mitotic Progression | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Nuclear Pore Complex (NPC) Disassembly | |
Phosphorylation of Emi1 | |
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
Phosphorylation of the APC/C | |
Polo-like kinase mediated events | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of HSF1-mediated heat shock response | |
Regulation of PLK1 Activity at G2/M Transition | |
Resolution of Sister Chromatid Cohesion | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
T41 mutants of beta-catenin aren't phosphorylated | |
truncations of AMER1 destabilize the destruction complex | |
XBP1(S) activates chaperone genes |
No pre-computed analogs available. Try a structural similarity search.